Your browser doesn't support javascript.
loading
Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2.
Li, Yinlong; Dahl, Kenneth; Johnström, Peter; Varnäs, Katarina; Farde, Lars; Halldin, Christer; Medd, Amy; Maier, Donna; Powell, Mark E; Chen, Jiahui; Van, Richard; Patel, Jimmy; Chaudhary, Ahmad; Gao, Yabiao; Song, Zhendong; Haider, Ahmed; Shao, Yihan; Elmore, Charles S; Liang, Steven; Schou, Magnus.
Afiliação
  • Li Y; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Dahl K; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Karolinska Institutet, Stockholm S-17176, Sweden.
  • Johnström P; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm S-17176, Sweden.
  • Varnäs K; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Karolinska Institutet, Stockholm S-17176, Sweden.
  • Farde L; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm S-17176, Sweden.
  • Halldin C; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm S-17176, Sweden.
  • Medd A; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm S-17176, Sweden.
  • Maier D; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm S-17176, Sweden.
  • Powell ME; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Wilmington, Delaware 19803, United States.
  • Chen J; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Wilmington, Delaware 19803, United States.
  • Van R; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Wilmington, Delaware 19803, United States.
  • Patel J; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Chaudhary A; Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019-5251, United States.
  • Gao Y; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Song Z; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Haider A; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Shao Y; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Elmore CS; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Liang S; Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019-5251, United States.
  • Schou M; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Wilmington, Delaware 19803, United States.
ACS Pharmacol Transl Sci ; 7(8): 2414-2423, 2024 Aug 09.
Article em En | MEDLINE | ID: mdl-39144551
ABSTRACT
The metabotropic glutamate receptor 2 (mGluR2) has emerged as a potential therapeutic target for the treatment of various neurological diseases, prompting substantial interest in the development of mGluR2-targeted drug candidates. As part of our medicinal chemistry program, we synthesized a series of isoindolone derivatives and assessed their potential as mGluR2 positive allosteric modulators (PAMs). Notably, AZ12559322 exhibited high affinity (K i mGluR2 = 1.31 nM) and an excellent in vitro binding specificity of 89% while demonstrating selectivity over other mGluR subtypes (>4000-fold). Autoradiography with the radiolabeled counterpart, [3H]AZ12559322, revealed a heterogeneous accumulation with the highest binding in mGluR2-rich brain regions. Radioligand binding was significantly reduced by pretreatment with nonradioactive mGluR2 PAMs in brains of rats and nonhuman primates. Although positron emission tomography imaging of [11C]AZ12559322 (6a) revealed low brain uptake in a nonhuman primate, this study provides valuable guidance to further design novel isoindolone-based mGluR2 PAMs with improved brain exposure.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos